[Experience in the treatment of autoimmune male infertility in patients with category 4 chronic prostatitis]

Insights

Longidaza significantly reduces antisperm antibodies (ASAB) in men with chronic prostatitis, improving fertility outcomes. Treatment led to high rates of spontaneous and IVF pregnancy, supporting its use in autoimmune infertility.

Area of Science:

  • Reproductive Immunology
  • Pharmacology
  • Urology

Context:

  • Elevated antisperm antibodies (ASAB) are a significant factor in male infertility.
  • Chronic prostatitis can be associated with increased ASAB levels.
  • Autoimmune infertility impacts a considerable number of couples seeking conception.

Purpose:

  • To evaluate the efficacy of Longidaza in reducing ASAB levels in patients with chronic prostatitis.
  • To assess the impact of Longidaza treatment on spontaneous and assisted reproductive technology (ART) pregnancy rates.
  • To determine the long-term effects of Longidaza on ASAB levels post-treatment.

Summary:

  • Longidaza administration (3000 IU IM twice weekly) significantly reduced sperm surface MARIgG and MARIgA levels within one month.
  • Maximum ASAB reduction was observed after three months of treatment, with sustained low levels post-cessation in most patients.
  • Spontaneous pregnancies occurred in 10% of couples, and IVF was successful in 5% during the study period.

Impact:

  • Longidaza demonstrates high efficacy as a pathogenetic agent for treating autoimmune infertility in men with chronic prostatitis and elevated ASAB.
  • The study supports the use of Longidaza for patients undergoing ART or attempting natural conception.
  • This therapeutic approach offers a potential solution for couples facing challenges with immunological infertility.

Related Concept Videos

Infertility in Males01:23

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
709
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.5K
Spermatogenesis01:41

Spermatogenesis

Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male...
125.0K
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
991
Infertility in Females01:28

Infertility in Females

Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
5.1K